Connect with us


Why Moderna Stock Climbed Today – Motley Fool

One analyst sees gains of nearly 40% ahead for the biotech’s shareholders.



Article feature image

What happened
Shares of Moderna (NASDAQ:MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker’s growth prospects. 
So what
Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna’s stock and boosted his price forecast from $208 to $234 on Thursday. His new price target represents potential returns to shareholders of roughly 37% from Moderna’s current share price near $170. 
Moderna’s stock price is up sharply in recent days. Image…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
One quarter of vaccines sitting unused – Shepparton News
Article feature image
Genetics: COVID tech advances driving rapid diagnostic developments in beef industry – Beef Central